HHL-B:CA:TSX-Harvest Healthcare Leaders Income ETF (CAD)

ETF | Others |

Last Closing

CAD 9.03

Change

-0.02 (-0.22)%

Market Cap

N/A

Volume

124.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.52 (+1.92%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 4.87B
PHYS-U:CA Sprott Physical Gold Trust

-0.10 (-0.55%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.17 (+0.26%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

+0.58 (+1.41%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.07 (-0.32%)

CAD 3.78B
XEQT:CA iShares Core Equity Portfolio

+0.16 (+0.53%)

CAD 3.29B
PSLV-U:CA Sprott Physical Silver Trust

N/A

CAD 3.29B
IGAF:CA IA Clarington Loomis Global Al..

+0.04 (+0.29%)

CAD 3.23B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

CAD 2.78B

ETFs Containing HHL-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.74% 65% D 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.74% 64% D 57% F
Trailing 12 Months  
Capital Gain 1.80% 38% F 46% F
Dividend Return 0.65% 29% F 9% A-
Total Return 2.46% 38% F 41% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.76% 62% D 50% F
Dividend Return 1.82% 61% D- 44% F
Total Return 0.05% 54% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 4.16% 80% B- 91% A-
Risk Adjusted Return 43.67% 78% C+ 69% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike